ArticleHaematologica2025

Blinatumomab in induction therapy improves molecular response in untreated adults with Ph- B-cell precursor acute lymphoblastic leukemia.

Cyril Salek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.